Abiopharma

UTHR: Notification

UTHR: Notification

Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations on Wednesday, November 19, 2025

Mettler-Toledo International Inc. to Present at Upcoming Investor Conferences

Bausch + Lomb to Participate in Citi Global Healthcare Conference

Henlius et Organon annoncent lapprobation de la FDA américaine pour le POHERDY® (pertuzumab-dpzb), le premier biosimilaire de PERJETA (pertuzumab) aux États-Unis

UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DIVIDEND

Brookdale Senior Living Inc. - Brookdale Announces Chief Operating Officer

Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease

Jazz Pharmaceuticals to Participate in Citis 2025 Global Healthcare Conference